Isa F, Forleo-Neto E, Meyer J, Zheng W, et al. Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19. Int J Infect Dis 2022 Jul 1. pii: S1201-9712(22)00380.
PMID: 35788416